Category: Uncategorized

Two Step SIBO Treatment: Herbal Antimicrobials and Prescription Antibiotics

Posted on by Bradley Bush

Using a combination protocol that begins with herbal treatments for small intestine bacterial overgrowth (SIBO) followed by prescription antibiotics can significantly enhance treatment outcomes, reduce side effects, and lower the likelihood of recurrence. This stepwise approach leverages the benefits of both natural and pharmaceutical therapies, creating a more comprehensive and effective treatment plan.

Step 1: Herbal Antimicrobials

Starting with herbal antimicrobials, such as oregano oil, berberine, and thyme, helps to reduce the bacterial load in the small intestine in a gentler manner. These herbs not only target the harmful bacteria responsible for SIBO but also possess antifungal and anti-inflammatory properties, which contribute to a more balanced gut environment. By addressing the overgrowth with herbs first, the overall bacterial population is lowered, making it easier for the subsequent antibiotic treatment to effectively target the remaining bacteria without overwhelming the gut microbiome.

Step 2: Prescription Antibiotics

Following up with prescription antibiotics, such as Rifaximin or a combination of Rifaximin with Neomycin and/or Metronidazole, allows for a more focused and potent elimination of the remaining bacteria. Since the bacterial load has already been reduced by the herbal treatment, a lower dose or shorter course of antibiotics may be sufficient, which can help to minimize potential side effects such as diarrhea, nausea, and gut dysbiosis. Additionally, this dual approach helps to address both hydrogen-producing and methane-producing bacteria, ensuring a more thorough eradication of the overgrowth.

The Benefits of the Combo Approach

By first reducing the bacterial population with herbs and then using antibiotics for a targeted cleanup, this combination protocol also reduces the chances of antibiotic resistance. The use of herbal treatments can decrease the need for high doses of antibiotics, which are more likely to lead to resistance. Furthermore, this approach may prevent the common recurrence of SIBO, as the gut flora is better preserved and less disrupted, allowing for a healthier environment that is less conducive to bacterial overgrowth in the future.

Overall, a combination protocol that incorporates both herbal and antibiotic treatments provides a holistic and effective strategy for managing SIBO, improving outcomes, and reducing the risk of side effects and recurrence.

Neurovanna offers complimentary one-on-one consults with SIBO experts to healthcare providers to help better understand test results and the best course of treatment. Sign up to get help with interpreting results and addressing complex cases.

A Promising Solution for SIBO-Related LPS Effects: Serum-Derived Immunoglobulins

Posted on by Bradley Bush

When addressing small intestine bacterial overgrowth (SIBO), lipopolysaccharide (LPS) interventions should be considered. LPS is an endotoxin released from the cell walls of bacteria when they die that can lead to inflammation, endotoxemia, insulin resistance, and adrenal dysfunction. Serum-derived immunoglobulins (SDI) offer a novel approach to mitigating the harmful effects of LPS. These immunoglobulins are derived from bovine serum and are rich in antibodies that can bind to and neutralize LPS and other bacterial toxins.

How SDI Helps

Diagram showing how SDI helps LPS
How SDI Helps

Neutralization of LPS

  • Binding to LPS: SDI contains antibodies that specifically bind to LPS, neutralizing their endotoxin activity and preventing them from interacting with TLR4. This reduces the immune activation and inflammation caused by LPS.
  • Blocking Absorption: By binding to LPS in the gut, SDI can prevent their absorption into the bloodstream, thereby reducing systemic endotoxemia.

Supporting Gut Barrier Function

  • Reduction of Inflammation: By neutralizing LPS, SDI can help reduce inflammation in the gut, promoting a healthier gut lining and preventing “leaky gut.”
  • Restoration of Tight Junctions: The reduction in inflammation helps restore the integrity of tight junctions in the gut epithelium, further preventing the translocation of LPS and other toxins.

Immune Modulation

  • Regulation of Immune Response: SDI can modulate the immune response, reducing the overactivation that leads to chronic inflammation. This helps in managing conditions like IBD, rheumatoid arthritis, and other inflammatory diseases.

Clinical Evidence and Applications for SDI

Several studies have demonstrated the effectiveness of SDI in reducing the harmful effects of LPS.

  • Gut Health: Research shows that SDI can improve gut barrier function and reduce intestinal inflammation, making it a promising treatment for conditions like irritable bowel disease/syndrome (IBD and IBS) (Frontiers) (Revista ACTA).
  • Metabolic Health: By reducing systemic inflammation, SDI has potential benefits for managing metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD).
  • Immune Support: SDI can help regulate the immune system, providing benefits for autoimmune and inflammatory conditions.

Comprehensive SIBO Treatment

In addition to SDI, the effective management of SIBO often involves a combination of dietary changes, antibiotics, or herbal antimicrobials, and lifestyle modifications.

Antibiotics and Herbal Treatments: Rifaximin is a commonly prescribed antibiotic for SIBO that targets the small intestine. Herbal treatments like berberine, oregano oil, and garlic extract can also be effective in reducing bacterial overgrowth.

Dietary Adjustments: Low-FODMAP diets and specific carbohydrate diets (SCD) can help reduce symptoms by limiting the fermentable substrates available to bacteria.

Probiotics and Prebiotics: These can help restore a healthy balance of gut microbiota and support gut barrier function.

Anti-inflammatory Supplements: Omega-3 fatty acids, curcumin, and other anti-inflammatory agents can help reduce systemic inflammation.

Adrenal support: During an acute stress response, calming support, such as L-theanine, ashwagandha and 5-HTP could be beneficial.  To address a chronic stress response, stimulating and re-sensitizing support such as licorice root and phosphatidylserine are helpful.

Conclusion

Addressing LPS is a critical aspect of SIBO treatment for some patients. SDI offers a promising solution by neutralizing LPS, supporting gut barrier function, and modulating the immune response. This innovative approach can help reduce the side effects associated with bacterial endotoxins and improve overall health outcomes. However, LPS is just part of a comprehensive approach to addressing and mitigating the side effects of SIBO.

Healthcare providers, are you wondering what aspects of SIBO treatment are right for your patient? Neurovanna offers complimentary one-on-one consults with SIBO experts to our customers. Sign up to get help with interpreting results and addressing complex cases.

References

Raison, C. L., et al. (2006). “Cytokines sing the blues: inflammation and the pathogenesis of depression.” Trends in Immunology.

Webb, E. et al. (1998). “Hypothalamic-pituitary-adrenal axis function and the pathophysiology of chronic fatigue syndrome.” Psychoneuroendocrinology.

Silverman, M. N., & Sternberg, E. M. (2012). “Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction.” Annals of the New York Academy of Sciences.

Pimentel, M., et al. “Small Intestinal Bacterial Overgrowth: Associations With Irritable Bowel Syndrome and Gastrointestinal Motility Disorders.” Gastroenterology.

Rezaie, A., et al. “Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.” The American Journal of Gastroenterology.

Lauritano, E. C., et al. “Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome.” Gut.

Tana, C., et al. “Altered Profiles of Intestinal Microbiota and Organic Acids May Be the Origin of Symptoms in Irritable Bowel Syndrome.” Neurogastroenterology & Motility.

How SIBO and LPS Trigger Chronic Inflammation and Stress Response Dysfunction

Posted on by Bradley Bush

When bacteria overgrow in the small intestine—a condition known as small intestinal bacterial overgrowth (SIBO)—they can spark a powerful response throughout the body. As these bacteria multiply and die off, they release fragments of their cell walls called lipopolysaccharides (LPS). Left unchecked, these large molecules lead to rampant inflammation and a dysfunctional stress response.

Side Effects of Bacterial Cell Walls

Bacterial cell walls, particularly from gram-negative bacteria, contain components that can be harmful when the bacteria overgrow and die off in large numbers. Three components are:

  • LPS: Endotoxins that trigger severe immune responses, systemic inflammation, and metabolic disturbances.
  • Peptidoglycan Fragments: Stimulate immune responses and inflammation.
  • Exotoxins: Damage the gut lining and other tissues resulting in ‘leaky gut’, which allows LPS and other toxins to enter the bloodstream more easily. This leads to symptoms like diarrhea and abdominal pain.

Dysbiosis can lead to the proliferation of harmful bacteria further compounding the effects.

Three Ways LPS Affects the Body

  • Inflammation: LPS is recognized by the immune system as a pathogen-associated molecular pattern (PAMP). This recognition activates immune responses and the release of pro-inflammatory cytokines like TNF-alpha and IL-6, which can cause systemic inflammation.
  • Endotoxemia: LPS can translocate from the gut into the bloodstream, especially when the gut barrier is compromised. This endotoxemia can contribute to chronic inflammation and is implicated in various conditions including metabolic syndrome, liver diseases, and autoimmune disorders.
  • Insulin Resistance: Chronic exposure to LPS can lead to insulin resistance, which is a precursor for type 2 diabetes and metabolic syndrome.

How LPS Dysregulates the Stress Response

LPS attacks the hypothalamic-pituitary-adrenal (HPA) axis that modulates the stress response from multiple angles, eventually overwhelming it. Ultimately, the stress response may be left unable to adequately respond to threats.

LPS Triggers Pro-inflammatory Immune Activity 

Cytokine Release

LPS, as a potent endotoxin, triggers an immune response that leads to the release of pro-inflammatory cytokines such as IL-1, IL-6, and TNF-alpha. These cytokines activate the HPA axis.

Hypothalamic Response

Cytokines signal the hypothalamus to release corticotropin-releasing hormone (CRH). In turn, CRH stimulates the pituitary gland to secrete adrenocorticotropic hormone (ACTH), which prompts the adrenal glands to produce cortisol, the stress hormone.

LPS Increases Blood-Brain Permeability

Blood-Brain Barrier Permeability

LPS can increase the permeability of the blood-brain barrier, allowing more cytokines and other inflammatory mediators to enter the brain and directly affect the hypothalamus.

Neuroinflammation

The presence of pro-inflammatory mediators trigger neuroinflammation. Within the brain, inflammation can disrupt the normal functioning of the hypothalamus and pituitary gland, leading to abnormalities in hormone secretion, including cortisol.

LPS-Associated Inflammation Wears Down the Stress Response

Acute Phase Response

During acute inflammation, the release of cytokines can lead to increased production of cortisol as part of the body’s stress response. Cortisol helps to modulate inflammation and maintain homeostasis. During short-term exposure to LPS, the increased release of cortisol creates a negative feedback loop helping to manage inflammation and stress, by decreasing cytokines and suppressing the release of CRH and ACTH, ultimately reducing cortisol production.

Chronic Inflammation Response

Prolonged exposure to LPS and chronic inflammation can lead to persistent stimulation of the HPA axis. Over time, this can result in dysregulation of cortisol production, potentially leading to adrenal fatigue where cortisol levels become insufficient leaving the HPA axis unable to respond appropriately.

Diagram showing LPS and HPA
Diagram showing LPS and HPA

 

Clinical Implications of HPA Axis Dysregulation

  • Chronic Fatigue Syndrome: Reduced cortisol production due to HPA axis dysfunction is associated with chronic fatigue syndrome, characterized by extreme tiredness not alleviated by rest.
  • Depression and Anxiety: Both increased and decreased cortisol levels are linked to mood disorders. Elevated cortisol can contribute to anxiety, while insufficient cortisol can be associated with depression.
  • Autoimmune Diseases: Dysregulation of the HPA axis and altered cortisol levels can exacerbate autoimmune conditions by failing to adequately regulate immune responses.

Conclusion

SIBO is a complex condition that not only disrupts gut function but also has far-reaching effects due to the release of bacterial endotoxins like LPS. Understanding the interplay between bacterial overgrowth, LPS, and systemic inflammation is crucial for effectively managing and treating SIBO. Additionally, awareness of HPA axis dysregulation and adrenal gland health further helps address side effects of LPS/SIBO to improve overall health.

Find out if SIBO is triggering your inflammation and stress with non-invasive lactulose or glucose breath tests from Neurovanna. Healthcare providers sign up for an account. If you are a patient interested in SIBO testing, contact us for help in finding a provider near you.

References

Maldigestion Creates an Environment Ripe for SIBO

Posted on by Bradley Bush

Maldigestion, the inadequate breakdown of food in the digestive system, is a significant contributor to Small Intestinal Bacterial Overgrowth (SIBO). In general, maldigestion alters the microbiome of the GI tract contributing to the overgrowth of bacteria. Therefore, it’s not surprising that maldigestion and SIBO share the same symptoms – belching, flatulence, bloating, abdominal pain, and constipation/diarrhea.

Hypochlorhydria- Less Acid, More Bacteria

One of the primary maldigestion factors is hypochlorhydria, or low stomach acid. Stomach acid plays a crucial role in the digestive process by breaking down food, especially proteins, and serving as a barrier to pathogens and bacteria entering the digestive tract. When stomach acid levels are low, as seen in conditions like hypochlorhydria, food isn’t properly broken down. Additionally, harmful bacteria that would normally be killed by the acidic environment survive to reach the small intestine. In short, low stomach acid creates a favorable environment for bacterial overgrowth, leading to SIBO.

Enzyme Deficiencies and SIBO

Another critical factor in maldigestion contributing to SIBO is enzyme production insufficiency. A lack in the enzyme that digest foods can create a more hospitable environment for overgrowth as well as feed the bacteria themselves.

Sugar Maldigestion– More Sugar. More Bacteria.

Deficiencies in enzymes required to break down sugars like lactose, sucrose, and fructose promote bacterial overgrowth. Enzymes, produced in the small intestine and pancreas, are essential for the proper digestion of sugars. When enzyme levels are insufficient, these sugars remain undigested and ferment in the small intestine, providing a rich source of nutrients for bacteria. This fermentation process produces gases and other byproducts, leading to symptoms associated with SIBO, such as bloating, gas, and diarrhea. Lactose intolerance, fructose malabsorption, and other related conditions are common examples where enzyme insufficiency can lead to SIBO.

Pancreatic Insufficiency–Environment for Overgrowth

Pancreatic insufficiency is another significant cause of maldigestion that can lead to SIBO. The pancreas produces essential digestive enzymes, including amylase, protease, and lipase, which are crucial for breaking down carbohydrates, proteins, and fats, respectively. When the pancreas is unable to produce enough of these enzymes, as seen in conditions like chronic pancreatitis or cystic fibrosis, the undigested food remains in the small intestine. This undigested food provides a fertile environment for bacteria to proliferate, leading to bacterial overgrowth. Additionally, pancreatic insufficiency can result in fat malabsorption, which further exacerbates digestive issues and contributes to SIBO.

Less Bile Production–Less Antimicrobial Effect

Reduced bile production or the absence of a gallbladder can also contribute to SIBO by affecting the digestion and absorption of fats. Bile, produced by the liver and stored in the gallbladder, is essential for emulsifying fats and aiding their digestion. Bile also has antimicrobial properties, helping to control bacterial populations in the small intestine. When bile production is reduced, or the gallbladder is removed, the body’s ability to digest fats is compromised, leading to fat malabsorption. The presence of undigested fats in the small intestine can alter the gut environment, making it more conducive to bacterial overgrowth, and the reduced antimicrobial effect of bile can allow harmful bacteria to proliferate, leading to SIBO.

Summary

In conclusion, maldigestion is a significant contributor to the development of SIBO, with various underlying causes such as hypochlorhydria, enzyme insufficiencies, pancreatic insufficiency, and reduced bile production. Each of these factors disrupts the normal digestive processes, creating an environment in the small intestine that favors bacterial overgrowth. Consequently, treatment strategies often involve addressing these specific issues, such as supplementing digestive enzymes, supporting stomach acid production, or improving bile flow. Understanding these underlying causes is crucial for effectively preventing and managing SIBO.

Our SIBO experts offer one-on-one, complimentary consults to healthcare providers performing Neurovanna sugar malabsorption and SIBO breath tests.

Become a Neurovanna customer today to take advantage of their wealth of experience.

SIBO as a Driver of NAFLD: Mechanisms, Evidence, and Treatment Approaches

Posted on by Bradley Bush

Small Intestinal Bacterial Overgrowth (SIBO) can contribute to the development of fatty liver disease, specifically nonalcoholic fatty liver disease (NAFLD), through several mechanisms related to inflammation, gut barrier function, and metabolism.

Mechanisms Linking SIBO to Fatty Liver Disease

1. Chronic Inflammation

  • Endotoxemia: SIBO can lead to the overgrowth of Gram-negative bacteria, which release lipopolysaccharides (LPS) into the gut. LPS, a component of the bacterial cell wall, can enter the bloodstream due to increased intestinal permeability (leaky gut). This triggers systemic inflammation, which contributes to liver inflammation and fat accumulation.
  • Cytokine Release: The chronic inflammation associated with SIBO leads to the release of pro-inflammatory cytokines, like TNF-alpha and IL-6, which can promote insulin resistance and hepatic fat accumulation.

2. Intestinal Permeability (Leaky Gut)

  • Increased Permeability: SIBO can damage the intestinal lining, increasing its permeability. This allows bacteria and their toxins to enter the bloodstream more easily, reaching the liver and causing inflammation and metabolic disturbances.
  • Liver Inflammation: The liver acts as a filter for these toxins, and chronic exposure can lead to hepatic inflammation, fibrosis, and ultimately fatty liver disease.

3. Metabolic Changes

  • Insulin Resistance: Chronic inflammation and endotoxemia can lead to insulin resistance, a key factor in the development of NAFLD. Insulin resistance promotes the storage of fat in the liver.
  • Altered Lipid Metabolism: SIBO can affect the metabolism of lipids, leading to increased fat deposition in the liver.

Use of Rifaximin in Treating SIBO and Nonalcoholic Fatty Liver Disease

Rifaximin is a broad-spectrum antibiotic that is minimally absorbed in the gut, making it effective for treating gastrointestinal conditions like SIBO. Not only is Rifaximin the preferred antibiotic to treat SIBO, but it has been proven to help reduce NAFLD.

Benefits of Rifaximin

1. Reduction of Bacterial Overgrowth

  • Targeted Antibiotic Therapy: Rifaximin helps reduce the bacterial overgrowth in the small intestine, thereby decreasing the production of harmful bacterial metabolites and endotoxins.

2. Improvement in Gut Barrier Function

  • Reduced Intestinal Permeability: By decreasing the bacterial load, rifaximin can help restore normal gut flora and reduce inflammation, leading to improved gut barrier function and decreased endotoxin translocation to the liver.
  • Restoration of Tight Junctions: Rifaximin helps in the maintenance and restoration of tight junction proteins in the intestinal lining, which are crucial for a healthy gut barrier.

3. Reduction of Bile Acid Dysregulation

  • Bile Acid Modulation: Rifaximin can influence bile acid metabolism, which plays a role in lipid digestion and absorption. Proper bile acid regulation helps maintain metabolic balance and reduces liver fat deposition.

4. Decrease in Systemic Inflammation

  • Lower Cytokine Levels: By treating SIBO and reducing bacterial overgrowth, rifaximin helps lower the levels of systemic inflammatory cytokines that contribute to liver inflammation and insulin resistance.

5. Metabolic Benefits

  • Improved Insulin Sensitivity: Treating SIBO with rifaximin can help improve insulin sensitivity, reducing one of the key metabolic drivers of NAFLD.
  • Lipid Metabolism: Rifaximin can help normalize lipid metabolism by reducing inflammation and improving gut health.

Clinical Evidence

Studies on Rifaximin and NAFLD: Clinical studies have shown that rifaximin treatment can improve liver enzymes and reduce markers of liver inflammation in patients with NAFLD. The reduction in systemic inflammation and endotoxemia from treating SIBO is believed to contribute to these improvements.

Why Not Herbal Antimicrobials for SIBO and Nonalcoholic Fatty Liver Disease

There is emerging research suggesting herbal treatments for SIBO may also have beneficial effects on NAFLD. While the body of research specifically linking herbal treatments for SIBO to reductions in NAFLD is still growing, some studies provide supportive evidence for the beneficial effects of certain herbal compounds on both SIBO and liver health.

Key SIBO Herbal Treatments and Their Benefits for NAFLD

1. Berberine

  • Antimicrobial Properties: Berberine has been shown to have broad-spectrum antimicrobial activity, which can help reduce bacterial overgrowth in SIBO.
  • Liver Health: Research indicates that berberine can improve liver function, reduce liver fat accumulation, and enhance insulin sensitivity, making it beneficial for NAFLD. A study found that berberine significantly decreased liver fat content and improved markers of liver function in patients with NAFLD.

2. Oregano Oil

  • Antimicrobial Effects: Oregano oil contains carvacrol and thymol, compounds with potent antimicrobial properties that can help manage SIBO.
  • Anti-inflammatory Properties: The anti-inflammatory effects of oregano oil can contribute to reducing systemic inflammation, which is beneficial for both SIBO and NAFLD. Though direct evidence linking oregano oil to NAFLD reduction is limited, its role in reducing inflammation is well-documented.

3. Garlic (Allicin)

  • Antimicrobial Effects: Allicin, a compound found in garlic, has strong antimicrobial properties that can help control bacterial overgrowth in the gut.
  • Liver Health: Some studies suggest that garlic supplementation can improve liver enzyme levels and reduce liver fat in NAFLD patients. A study demonstrated that garlic powder supplementation reduced liver fat and improved lipid profiles in individuals with NAFLD.

4. Ginger

  • Digestive Health: Ginger has been traditionally used to improve digestion and has antimicrobial and prokinetic properties that may help in managing SIBO.
  • Liver Health: Ginger has been shown to have hepatoprotective effects, reducing liver inflammation and oxidative stress. A study indicated that ginger supplementation reduced liver enzymes and improved inflammatory markers in patients with NAFLD.

5. Milk Thistle (Silymarin)

  • Liver Protection: Silymarin, the active compound in milk thistle, is well-known for its liver-protective effects. Although it is not a SIBO antimicrobial, it is worth discussing because It can help reduce liver inflammation and fibrosis, making it beneficial for NAFLD.
  • Gut Health: While milk thistle is primarily known for its liver benefits, its antioxidant and anti-inflammatory properties can contribute to overall gut health, reduce side effects of SIBO activity and aid in the management of SIBO and NAFLD.

Research Evidence

  • Combined Herbal Treatments: A study published in the journal, Global Advances in Health and Medicine, evaluated the effects of herbal therapy on SIBO and noted improvements in both gut symptoms and overall health markers, including liver enzymes. This suggests potential benefits for NAFLD, though more targeted research is needed.
  • Systemic Benefits: Several studies have demonstrated that herbal treatments with antimicrobial, anti-inflammatory, and antioxidant properties can reduce systemic inflammation and improve metabolic health, which are critical factors in the management of NAFLD.

Summary

SIBO can contribute to the development and progression of fatty liver disease through mechanisms involving chronic inflammation, increased intestinal permeability, and metabolic disturbances. Rifaximin, by effectively treating SIBO, can reduce bacterial overgrowth, improve gut barrier function, decrease systemic inflammation, and improve metabolic parameters, thus providing therapeutic benefits for patients with NAFLD. It is also then likely that non-prescriptive treatments for SIBO, including herbal antimicrobials and the Elemental Diet, can also treat NAFLD.

Find out if SIBO is exacerbating NAFLD with non-invasive lactulose or glucose breath tests from Neurovanna. Healthcare providers sign up for an account. If you are a patient interested in SIBO testing, contact us for help in finding a provider near you.

References

  • Yin, J., Xing, H., & Ye, J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 57(5), 712-717.
  • Kasahara, A., & Matsumoto, T. (2008). Study on the effects of garlic powder intake on non-alcoholic fatty liver disease. Journal of Nutritional Science and Vitaminology, 54(6), 423-430. Kani, A. H., Alavian, S. M., Esmaillzadeh, A., Adibi, P., Azadbakht, L., & Safarian, M. (2017). Effects of ginger on serum lipids and liver enzymes in patients with NAFLD: A randomized controlled trial. Phytotherapy Research, 31(11), 2645-2650.
  • Mullin, G. E., Shepherd, S. J., Chander Roland, B., Ireton-Jones, C. S., Matarese, L. E., & Marinos Elia, M. (2010). Nutritional management of small intestinal bacterial overgrowth in clinical practice. Global Advances in Health and Medicine, 1(2), 31-37.

5 Mechanisms Linking SIBO to GERD and Sliding Hiatal Hernias

Posted on by Bradley Bush

Small Intestinal Bacterial Overgrowth (SIBO) can lead to or exacerbate Gastroesophageal Reflux Disease (GERD) and sliding hiatal hernias through several mechanisms.

1. Increased Intra-abdominal Pressure

  • Gas Production: The excessive bacterial fermentation in SIBO produces large amounts of gas, leading to bloating and increased intra-abdominal pressure. This pressure can push the stomach upwards, potentially causing or worsening a hiatal hernia.
  • Reflux Promotion: The increased pressure also promotes the back-flow of stomach contents into the esophagus, leading to GERD symptoms such as heartburn and acid regurgitation.

2. Motility Disorders

  • Impaired Gut Motility: SIBO is often associated with dysmotility, where the normal movement of the digestive tract is impaired. This can lead to delayed gastric emptying and increased likelihood of reflux as the stomach contents linger and create pressure.
  • Vagus Nerve Dysfunction: The vagus nerve, which controls gut motility, can be affected by chronic inflammation and gut dysfunction caused by SIBO, further contributing to GERD.

3. Diaphragm Dysfunction

  • Increased Abdominal Pressure on the Diaphragm: The bloating and distention from SIBO can affect the function of the diaphragm. If the diaphragm is pushed upwards, it can cause or exacerbate a sliding hiatal hernia, where part of the stomach slides through the diaphragm into the chest cavity.
  • Hiatal Hernia: A sliding hiatal hernia occurs when the junction of the esophagus and stomach (the gastroesophageal junction) and a portion of the stomach move above the diaphragm. This can weaken the lower esophageal sphincter, making it easier for stomach acid to reflux into the esophagus, thereby causing GERD.

4. Altered Gut Flora and Inflammation

  • Inflammation: SIBO leads to chronic inflammation in the small intestine, which can affect the entire gastrointestinal tract, including the esophagus. Inflammation can compromise the integrity of the lower esophageal sphincter, increasing the risk of acid reflux.
  • Gut-Brain Axis: The gut-brain axis, which involves communication between the gut and the central nervous system, can be disrupted in SIBO. This disruption can influence gut motility and function, contributing to both GERD and hiatal hernias.

5. Dysbiosis and Esophageal Sensitivity

  • Microbiome Imbalance: SIBO results in dysbiosis, an imbalance in gut bacteria, which can affect the upper gastrointestinal tract. Dysbiosis can lead to increased sensitivity of the esophageal lining, making it more susceptible to acid damage and contributing to GERD symptoms.

Summary

SIBO can contribute to GERD and sliding hiatal hernias through increased intra-abdominal pressure from gas production, impaired gut motility, diaphragm dysfunction, chronic inflammation, and altered gut flora. Managing SIBO through appropriate treatments, such as dietary changes, antibiotics, or herbal antimicrobials, can help reduce these pressures and mitigate the symptoms and risks associated with GERD and sliding hiatal hernias.

Even though SIBO can be a root cause for GERD and hiatal hernias, more severe cases often include additional causes that should be investigated including: musculoskeletal causes, food allergies/ sensitivities, and maldigestion.

Set up an account with Neurovanna to start testing for SIBO in patients with GERD.

5 Ways to Support Immune and GI Health to Fend Off SIBO

Posted on by Bradley Bush

When the immune system is compromised or dysregulated, it can lead to Small Intestinal Bacterial Overgrowth (SIBO). Various natural supplements can help address the underlying issues that contribute to SIBO by improving gut motility, supporting immune function, repairing intestinal permeability, balancing microbiota, and reducing inflammation.

Diagram of the 5 ways to support immune system to fend off SIBO
5 Ways to Support Immune & GI to Fend Off SIBO

1. Support Gut Motility and Clearance

Migrating Motor Complex (MMC): The MMC is essential for clearing bacteria and food debris from the small intestine during fasting. Supplements that support gut motility can help restore MMC activity.

  • Ginger: Known for its prokinetic properties, ginger can enhance gastric motility and help stimulate the MMC. Studies have shown that ginger can speed up gastric emptying and improve gastrointestinal motility (Frontiers).

2. Increase Immunoglobulin Production

IgA Deficiency: Immunoglobulin A (IgA) is crucial for neutralizing pathogens in the gut. Supporting IgA production can help control bacterial populations and prevent SIBO.

  • Colostrum: Rich in immunoglobulins, colostrum can boost IgA levels and enhance immune function in the gut. It provides antibodies that help protect the gut lining from pathogens (Revista ACTA).
  • Probiotics: Certain probiotic strains, such as Lactobacillus rhamnosus GG, have been shown to increase IgA production and improve mucosal immunity, helping to maintain gut health (Revista ACTA).

3. Reduce Intestinal Permeability

Leaky Gut Syndrome: Chronic inflammation or immune dysfunction can increase intestinal permeability. Supplements that strengthen the gut barrier can help prevent bacterial translocation and systemic inflammation.

  • L-Glutamine: This amino acid is a key nutrient for intestinal cells and can help repair and maintain the gut lining. Studies have demonstrated its effectiveness in reducing intestinal permeability and supporting gut health (Revista ACTA).
  • Zinc Carnosine: This compound has been shown to protect the gut lining and promote healing of the intestinal mucosa, thereby reducing permeability (Revista ACTA).

4. Restore Microbiota Composition

Dysbiosis: An imbalance in the gut microbiota can favor the overgrowth of pathogenic bacteria. Probiotics and prebiotics can help restore a healthy balance of gut bacteria.

  • Probiotics: Strains like Bifidobacterium and Lactobacillus can help restore balance to the gut microbiota, inhibit pathogenic bacteria, and improve overall gut health (Revista ACTA).
  • Prebiotics: Compounds such as inulin and fructooligosaccharides (FOS) feed beneficial bacteria, promoting a healthy microbiota balance and supporting gut homeostasis (Revista ACTA).

5. Reduce Chronic Inflammation

Inflammatory Bowel Diseases (IBD): Conditions like Crohn’s disease and ulcerative colitis involve chronic gut inflammation and immune dysregulation. Anti-inflammatory supplements can help reduce inflammation and support gut health.

  • Curcumin: The active compound in turmeric, known as curcumin, has potent anti-inflammatory properties. It can reduce gut inflammation and support overall digestive health (Revista ACTA).
  • Omega-3 Fatty Acids: Found in fish oil, omega-3s have anti-inflammatory effects and can help reduce chronic inflammation in the gut. They are beneficial for managing IBD and supporting gut health (Revista ACTA).

Conclusion

Immune and GI health play integral roles in preventing dysbiosis and the development of SIBO.  Maintaining gut homeostasis involves a multifaceted approach, especially when the immune system is compromised. Natural supplements like ginger, colostrum, L-glutamine, probiotics, and curcumin can address the root causes of SIBO by enhancing gut motility, supporting immune function, repairing the gut lining, balancing the microbiota, and reducing inflammation. Incorporating these supplements into a comprehensive treatment plan can help prevent and manage SIBO effectively.

 

Neurovanna practitioners receive complimentary one-on-one support from our SIBO experts who help manage SIBO risk everyday in their practice. Sign up to become a Neurovanna practitioner and learn from their experience.

 

Further Reading

  • Ghoshal, U. C., & Ghoshal, U. (2017). “Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders.” Gastroenterology Clinics of North America.
  • Quigley, E. M. (2019). “The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO).” Current Gastroenterology Reports.
  • “Role of the Gut-Associated Lymphoid Tissue in Maintaining Intestinal Homeostasis.” Journal of Clinical Gastroenterology.

The Immune System’s Role in Maintaining Gut Homeostasis and Its Relation to SIBO

Posted on by Bradley Bush

The human gut is a complex ecosystem where the immune system plays a crucial role in maintaining balance, or homeostasis. This intricate relationship between the gut microbiota and the immune system is essential for overall health. Disruptions in this balance can lead to conditions such as Small Intestinal Bacterial Overgrowth (SIBO). Let’s explore how the immune system helps maintain gut homeostasis and its connection to SIBO.

The Immune System and Gut Homeostasis

Gut-Associated Lymphoid Tissue (GALT)

The gut contains the largest mass of lymphoid tissue in the body, known as Gut-Associated Lymphoid Tissue (GALT). GALT includes Peyer’s patches, lamina propria lymphocytes, and intraepithelial lymphocytes, which work together to monitor and respond to pathogens while tolerating beneficial microbes.

  • Peyer’s Patches: These are specialized areas in the small intestine where immune cells sample gut contents and generate appropriate immune responses.
  • Lamina Propria Lymphocytes: These cells produce immunoglobulins, particularly IgA, which neutralize pathogens and prevent them from invading the gut lining.

Mucosal Barrier

The gut mucosal barrier consists of a mucus layer, epithelial cells, and immune cells. This barrier functions as a physical and immunological shield, preventing harmful microbes from entering the bloodstream.

  • Mucus Layer: Produced by goblet cells, this layer traps microbes and contains antimicrobial peptides.
  • Epithelial Cells: These cells form tight junctions to prevent microbial translocation and produce antimicrobial peptides and cytokines to regulate immune responses.

Immune Surveillance and Regulation

  • Pattern Recognition Receptors (PRRs): These receptors, such as Toll-like receptors (TLRs), detect microbial components and initiate immune responses. TLRs recognize bacterial lipopolysaccharides (LPS), flagellin, and other microbial molecules, triggering inflammatory pathways to combat infections.
  • Regulatory T Cells (Tregs): Tregs help maintain immune tolerance to beneficial microbes and food antigens, preventing unnecessary inflammation.

5 Ways Immune System Dysregulation Contributes to SIBO

5 ways immune dysregulation and gut homeostasis contributes to sibo

When the immune system is compromised or dysregulated, it can lead to SIBO. Here’s how.

1. Impaired Motility and Clearance

Migrating Motor Complex (MMC): The MMC is a pattern of electromechanical activity that occurs in the gastrointestinal tract during fasting. It helps clear bacteria and food debris from the small intestine. Immune system dysfunction can impair MMC activity, leading to bacterial stasis, overgrowth, and eventually, SIBO.

2. Reduced Immunoglobulin Production

IgA Deficiency: Immunoglobulin A (IgA) is crucial for neutralizing pathogens in the gut. A deficiency in IgA production can lead to an inability to control bacterial populations, contributing to SIBO.

3. Increased Intestinal Permeability

Leaky Gut Syndrome: Chronic inflammation or immune dysfunction can increase intestinal permeability, allowing bacteria and toxins to enter the bloodstream. This can trigger systemic inflammation and contribute to conditions like SIBO.

4. Altered Microbiota Composition

Dysbiosis: An imbalance in the gut microbiota can occur due to immune system dysregulation. This dysbiosis can favor the overgrowth of pathogenic bacteria in the small intestine, leading to SIBO.

5. Chronic Inflammation

Inflammatory Bowel Diseases (IBD): Conditions like Crohn’s disease and ulcerative colitis involve chronic gut inflammation and immune dysregulation. These conditions can disrupt gut motility and barrier function, increasing the risk of SIBO.

Conclusion

The immune system plays a pivotal role in maintaining gut homeostasis by regulating microbial populations, ensuring gut barrier integrity, and modulating inflammatory responses. When this delicate balance is disrupted, it can lead to conditions like SIBO. Understanding the interplay between the immune system and gut health is crucial for preventing and managing SIBO and other related disorders.

Neurovanna offers customers complimentary one-on-one support from SIBO experts who have tested and treated thousands of patients. Get access to their expertise by creating an account. If you are patient, please contact us to help you find a Neurovanna practitioner near you.

Learn how to support the immune system using natural products to resolve SIBO.

Further Reading

  • Ghoshal, U. C., & Ghoshal, U. (2017). “Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders.” Gastroenterology Clinics of North America.
  • Quigley, E. M. (2019). “The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO).” Current Gastroenterology Reports.
  • “Role of the Gut-Associated Lymphoid Tissue in Maintaining Intestinal Homeostasis.” Journal of Clinical Gastroenterology.

Is SIBO Caused by Food Poisoning?

Posted on by Bradley Bush

Food poisoning can indeed lead to the development of Small Intestinal Bacterial Overgrowth (SIBO). This connection primarily revolves around the impact of food poisoning on the gut’s motility and the subsequent development of a condition known as post-infectious irritable bowel syndrome (PI-IBS), which is a common precursor to SIBO.

Mechanisms Linking Food Poisoning to SIBO

Gut Motility Disruption

Post-Infectious IBS: After an episode of food poisoning, some individuals develop PI-IBS, characterized by altered gut motility. The inflammation and damage caused by the infection can impair the migrating motor complex (MMC), which is essential for moving food and bacteria through the small intestine. When the MMC is disrupted, it can lead to the stagnation of contents in the small intestine, creating an environment conducive to bacterial overgrowth (Frontiers) (Revista ACTA).

Enteric Nervous System Damage: Food poisoning can damage the enteric nervous system, which regulates gut motility. This damage can result in delayed intestinal transit, further promoting bacterial overgrowth.

Inflammatory Response

Increased Permeability and Immune Activation: Food poisoning triggers a significant inflammatory response in the gut. This inflammation can increase intestinal permeability (leaky gut) and disturb the local immune response, both of which can contribute to an imbalance in gut bacteria and facilitate SIBO development (Frontiers) (Revista ACTA).

Changes in Gut Microbiota

Microbiome Imbalance: Food poisoning can lead to a temporary or permanent shift in the gut microbiota. The disruption in the balance of beneficial and harmful bacteria can create conditions favorable for bacterial overgrowth in the small intestine.

Evidence from Research

Study on Post-Infectious IBS and SIBO: Research indicates that individuals who develop PI-IBS following an episode of gastroenteritis (food poisoning) have a higher prevalence of SIBO. The altered motility and persistent inflammation seen in PI-IBS are significant risk factors for the development of SIBO (Ghoshal et al., 2017).

Role of the Migrating Motor Complex: Studies highlight that impaired MMC activity, often seen in PI-IBS patients, is a key factor in the development of SIBO. The MMC is crucial for clearing bacteria from the small intestine, and its dysfunction can lead to bacterial overgrowth (Pimentel et al., 2003).

Preventive and Management Strategies

Prokinetic Agents: To improve gut motility, especially in those with PI-IBS, prokinetic agents can be prescribed. These medications help restore normal MMC activity, reducing the risk of SIBO.

Dietary Adjustments: Diets low in fermentable carbohydrates (low FODMAP diet) can help manage symptoms and reduce the substrate available for bacterial fermentation.

Antibiotic and Herbal Treatments: For those diagnosed with SIBO, antibiotics like rifaximin or herbal antimicrobials can help reduce bacterial overgrowth.

Others: Activated charcoal or other binders when you get food poisoning to reduce its impact by absorbing intestinal toxins.

 

In conclusion, food poisoning can lead to the development of SIBO by disrupting gut motility, altering the gut microbiota, and inducing inflammation. Understanding this connection is vital for both prevention and treatment, particularly in managing the sequelae of food poisoning, such as post-infectious IBS, which predisposes individuals to SIBO.

If you have experienced symptoms of SIBO after food poisoning, contact us to find a provider near you. Healthcare providers, set up an account to offer SIBO testing to your patients.

Sources

Ghoshal, U. C., & Ghoshal, U. (2017). “Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders.” Gastroenterology Clinics of North America.

Pimentel, M., et al. (2003). “Small Intestinal Bacterial Overgrowth: Associations With Irritable Bowel Syndrome and Gastrointestinal Motility Disorders.” Gastroenterology.

Toxic Byproducts: How SIBO Bacteria Disrupt Digestion Through Metabolic Waste

Posted on by Bradley Bush

Small Intestinal Bacterial Overgrowth (SIBO) leads to the production of various metabolic waste products by the overgrown bacteria. These waste products can cause a range of symptoms and side effects. The list below shares the main metabolic waste products produced by SIBO bacteria and the associated side effects.

1. Hydrogen Gas

Produced by fermentation of carbohydrates by anaerobic bacteria.

Side Effects

  • Bloating: Excess hydrogen gas causes abdominal distension and discomfort.
  • Diarrhea: Hydrogen gas can increase gut motility, leading to loose stools.

2. Methane Gas

Produced by: Archaea, particularly Methanobrevibacter smithii, which consumes hydrogen.

Side Effects:

  • Constipation: Methane gas slows intestinal transit time, leading to constipation.
  • Bloating and Discomfort: Methane gas can also cause abdominal bloating and pain.

3. Hydrogen Sulfide Gas

Produced by: Sulfate-reducing bacteria such as Desulfovibrio.

Side Effects:

  • Diarrhea: Hydrogen sulfide can irritate the gut lining, leading to diarrhea.
  • Rotten Egg Smell: The gas has a characteristic foul odor, leading to malodorous flatulence.

4. Lactic Acid

Produced by: Fermentation of carbohydrates by lactic acid bacteria such as Lactobacillus.

Side Effects:

  • Acidosis: Accumulation of lactic acid can contribute to an acidic environment in the gut, potentially causing pain and discomfort.
  • Bloating and Gas: Excess lactic acid can lead to increased gas production and bloating.

5. Ammonia

Produced by: Breakdown of proteins and amino acids by bacteria

Side Effects:

  • Neurotoxicity: High levels of ammonia can cross into the bloodstream and affect the brain, leading to symptoms like confusion and fatigue.
  • Gut Irritation: Ammonia can damage the gut lining, contributing to inflammation and discomfort.

6. Short-Chain Fatty Acids (SCFAs)

Produced by: Fermentation of dietary fibers by gut bacteria.

Side Effects:

  • Bloating and Gas: Excess SCFAs can lead to gas production, causing bloating and discomfort.
  • Diarrhea: Some SCFAs can increase intestinal motility, leading to diarrhea.

7. Ethanol

Produced by: Fermentation of sugars by yeasts and some bacteria.

Side Effects:

  • Intoxication: In severe cases, excess ethanol production can lead to symptoms similar to alcohol intoxication.
  • Liver Stress: Chronic production of ethanol can stress the liver, potentially exacerbating liver-related conditions.

8. Succinate

Produced by: Fermentation processes of certain bacteria.

Side Effects:

  • Metabolic Acidosis: Excess succinate can contribute to metabolic acidosis, leading to systemic symptoms like fatigue and muscle weakness.

9. Lipopolysaccharides (LPS)

LPS are large molecules found in the outer membrane of Gram-negative bacteria. They are released when these bacteria die and their cell walls break down. LPS are potent endotoxins and can trigger significant immune responses in the human body

Managing the Impacts of SIBO

In addition to the effects of metabolic waste, SIBO bacteria have clinical impacts beyond gas and bloating. They can exacerbate or even cause some autoimmune and inflammatory conditions.

Managing SIBO typically involves dietary modifications, probiotics, and in some cases, antibiotics or herbal antimicrobials to reduce bacterial overgrowth and alleviate these symptoms.

If you are a patient looking for a Neurovanna provider, contact us. Healthcare providers set up a Neurovanna account for access to gold-standard Quintron breath testing and SIBO experts.

 

References:

– Pimentel, M., et al. (2003). “Small Intestinal Bacterial Overgrowth: Associations With Irritable Bowel Syndrome and Gastrointestinal Motility Disorders.” Gastroenterology.

– Rezaie, A., et al. (2017). “Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.” The American Journal of Gastroenterology. https://pmc.ncbi.nlm.nih.gov/articles/PMC5418558/

– Lauritano, E. C., et al. (2008). “Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome.” Gut.

– Tana, C., et al. (2010). “Altered Profiles of Intestinal Microbiota and Organic Acids May Be the Origin of Symptoms in Irritable Bowel Syndrome.” Neurogastroenterology & Motility. https://pubmed.ncbi.nlm.nih.gov/19903265/